Allena Pharmaceuticals, Inc. (ALNA) |
| 0.075 0.002 (3.16%) 09-07 16:00 |
| Open: | 0.0641 |
| High: | 0.1459 |
| Low: | 0.06 |
| Volume: | 252,311,606 |
| Market Cap: | 0(M) |
| PE Ratio: | -0.12 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.15 |
| Resistance 1: | 0.09 |
| Pivot price: | 0.07 |
| Support 1: | 0.01 |
| Support 2: | 0.01 |
| 52w High: | |
| 52w Low: |
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.
Financials
| EPS | -1.010 |
| Book Value | 0.440 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -96.0 |
| Return on Equity (ttm) | -278.1 |
Company news
Fri, 29 Jul 2022
Hot Penny Stocks to Watch Before Market Open on July 29th - PennyStocks.com
Thu, 14 Jul 2022
Allena Pharma (ALNA) Stock Price Rallied 10.2% Today. Here’s Why. - AskTraders.com
Mon, 04 Jul 2022
What makes a stock a potential trade? - StocksToTrade
Wed, 04 May 2022
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering - Yahoo Finance
Sun, 10 Nov 2019
5 Top NASDAQ Biotech and Pharma Stocks: 65 Percent Rise for Clovis - Investing News Network
Thu, 07 Nov 2019
Allena Pharma Tumbles on Positive Study Results - Investing News Network
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
